$BNGO
Bionano Genomics Inc
PRICE
$1.35 β²0.746%
Extented Hours
VOLUME
5,856,477
DAY RANGE
1.31 - 1.4
52 WEEK
1.16 - 6.88
Join Discuss about BNGO with like-minded investors
@soheil.n #StockTraders.NET
IU Watchlist: Main Watches: $BBBY crazy AHs likely reactive trade off early pre market leave it ALONE into open and then looking for 945-10AM+ $MARA staying focused here I think we have a big trade coming soon. It does NOT mean BEARISH it has to stay heavy etc could be a lot like OCGN - home run and then it comes all the way back. $OCGN amazing one today but I don't expect that again - that's 2 times now we got a huge huge huge pay out. More it happens more people are prepared. Tomorrow is the big catalyst - be aware. Also they added a conference call on Nov 9th. Failed Follow Through: $GMBL watching - higher better for failed follow through set up. $SBEA ideally shove off open and look for back side. May swap to long bias if it holds trend next few days for T+2 $OLB higher better and looking for $5s - nice reads today hope comments helped $CRTX higher better tomorrow $17 + and fails $NXTD I think will be forgotten looking to fade it like today's home run Continuation: $BTTX watching weak open consolidate and rip r/g $BNGO sold a bunch re loaded the dip and letting it work until it doesn't like GEVO $CCNC notable buyer in tape. $IFRX so far so good from that swing idea $FGF has that 4AM type look to it - maybe a wild print see if it traps into 7AM if not be cautious if it stays heavy.
52 Replies 13 π 10 π₯
@portmoreute #ivtrades
definitely very volatile, I will say I've made the most on BNGO and SAVA though.
104 Replies 15 π 7 π₯
@FatassTrades #ivtrades
BNGO 07/16/2021 CALL $8.00 $16.1K $6.85 645 @ $0.25 15,134
119 Replies 13 π 8 π₯
@viking #StockTraders.NET
Upside: -RMED +45% (momentum) -LMNL +44% (momentum following FDA approval for its Biologics License Application for Ryplazim) -USCR +28% (to be acquired by Vulcan Materials for $74.00/shr in cash valued at $1.29B) -QTS +21% (to be acquired by Blackstone at $78.00/shr for a total transaction value of $10B) -BNGO +14% (names Jason Priar as its Chief Commercial Officer) -EVFM +14% (momentum) -MIC +12% (confirms to sell Atlantic Aviation unit for $4.48B in cash and assumed debt and reorganization obligations) -CDXC +11% (ChromaDex and Walmart launch Tru Niagen in 3,800 (from 3K prior) Walmart Stores Across the United States) -GIII +8.1% (earnings, guidance) -BLUE +7.4% (announces the Lifting of FDA Clinical Hold for Sickle Cell Disease and Γ-Thalassemia Studies) -VERU +5.0% (announces positive data at ASCO) -BIIB +4.7% (Biogen and Bio-Thera announce positive results from Phase 3 study of BAT1806) -NOVN +2.3% (results from Novanβs Exploratory Studies further demonstrate Antimicrobial Effect of NITRICILβ’ Platform Technology with NVN4100 in Companion Animal Health) -KKR +1.1% (MIC confirms to sell Atlantic Aviation unit for $4.48B in cash and assumed debt and reorganization obligations) Downside: -MOSY -12% (files to sell 1.8M shares at $7.15/shr for a total value of $13M) -PIXY -7.3% (files to sell up to 10.1M shares for holders) -WERN -2.0% (hearing cut at Goldman Sachs to Sell from Neutral) -MSTR -1.2% (to incur $284.5M impairment loss in Q2 due to fluctuations in Bitcoin; files to sell $400M of Senior secured 2028 notes)
91 Replies 10 π 9 π₯
@BrittJ #StockTraders.NET
Hopefully $BNGO will finally break down today. holding a swing from yesterday
114 Replies 10 π 12 π₯
Key Metrics
Market Cap
388.19 M
Beta
2.37
Avg. Volume
5.88 M
Shares Outstanding
289.70 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-03
Next Dividend Date
Company Information
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano's Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Bionano provides genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns.
CEO: R. Erik Holmlin
Website: bionanogenomics.com
HQ: 9540 Towne Centre Dr Ste 100 San Diego, 92121-1989 California
Related News